SCHEMBL5202842

SCHEMBL5202842

Nc1ncc(Oc2ccc(Cl)cc2)c(N2CCC(CO)C2)n1

nearest known ligand 0.52

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 8/20 0.40
HRH4 Q9H3N8 1/20 0.39
SYK P43405 1/20 0.39
FFAR4 Q5NUL3 1/20 0.38
ABL1 P00519 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708038 0.94 MAP4K4 (0.41)
SCHEMBL5205947 0.92 HRH4 (0.38) PDE10AHRH4FFAR4
SCHEMBL5209693 0.86 CNR2 (0.40) ABL1
SCHEMBL7716713 0.83 DHFR (0.39) PDE10AHRH4
SCHEMBL8137579 0.83 MEN1 (0.38) PDE10ASYK
SCHEMBL7708430 0.80 CYP3A4 (0.43)
SCHEMBL5204163 0.79 ADORA3 (0.44)
SCHEMBL7714137 0.78 LTA4H (0.51) HRH4
SCHEMBL7708442 0.78 LMNA (0.45) HRH4
SCHEMBL7714247 0.76 MEN1 (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP claimed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US claimed
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP disclosed
US-6916820-B1 Neurotrophic substituted pyrimidines KRENITSKY PHARMACEUTICALS, INC. (US) 2005-07-12 US disclosed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US disclosed